Rights and permissions
About this article
Cite this article
Fidaxomicin vs vancomycin for Clostridium difficile. Pharmacoecon. Outcomes News 663, 3 (2012). https://doi.org/10.2165/00151234-201206630-00005
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201206630-00005